Xeris Biopharma Holdings, Inc. ( XERS) - Key Metrics
XERS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.52 | $0.07 | $0.12 | $0.12 |
| 2025Q3 | $0.42 | $0 | $0.10 | $0.10 |
| 2025Q2 | $0.46 | -$0.01 | $0 | $0.06 |
| 2025Q1 | $0.39 | -$0.06 | -$0.07 | -$0.07 |
XERS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 29.39 |
| 2025Q3 | ? | 582.05 |
| 2025Q2 | ? | -94.45 |
| 2025Q1 | ? | -22.69 |
XERS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.97% | ? |
| 2025Q4 | 1.51% | ? |
| 2025Q3 | 1.25% | ? |
| 2025Q2 | -0.01% | ? |
| 2025Q1 | -1.20% | ? |
XERS
Price: $6.88
52 week price:
Earnings Per Share: 0.07 USD
P/E Ratio: 91.86
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 485000
Market Capitalization: 1.1 billion